Skip to main content
. 2024 Nov 26;2024(11):CD013707. doi: 10.1002/14651858.CD013707.pub2

2.1. Analysis.

2.1

Comparison 2: Pairwise analysis: levosimendan versus placebo, Outcome 1: All‐cause mortality within 30 days